Silversea has announced 103 new luxury cruise voyages for 2028-2029, covering 219 destinations in 56 countries. These itineraries highlight major cultural events like Carnival in Venice and Rio, New Year's Eve in Sydney, and Europe's truffle season through specialized culinary voyages. The program includes new ports across the Mediterranean, Caribbean, Asia, Australia, and South America, with unique experiences such as a private beach Carnival in Canouan and a 75-night Grand South America circumnavigation. General sales open on October 8, 2026, offering travelers immersive, authentic experiences worldwide.
Silversea's announcement of 103 new luxury cruise sailings for 2028-2029 provides context for consumer cyclical sector activity. For readers following this sector, here is Pluang's market snapshot as of Oct 07, 2026 01:21 WIB: Of 112 priced US Consumer Cyclical stocks, 73 rose and 39 fell. Notable movers include CAVA at USD 52.32 with a 1-day change of -3.29% and 100% buy order activity, BBWI at USD 18.02 with a +3.21% change and 100% buy order activity, and UAA at USD 4.83 with a +2.77% change but 100% sell order activity.
Neogen reported earnings per share of $0.08 and revenue of $222.8 million, both exceeding analyst expectations. The company also announced a strategic partnership with Hinalea Imaging Corp. to develop digital food safety tools. However, Neogen's stoc...
PepsiCo is set to report its Q3 2026 earnings with expectations of $2.29 EPS and $25 billion revenue. The company faces challenges in North America, where organic revenue declined due to pricing pressures and changing consumer preferences. To adapt, ...
Stryker experienced an 8.8% stock drop on September 8, 2026, wiping out over $10 billion in market value due to ongoing manufacturing problems that were thought resolved. Truist Financial lowered its price target from $340 to $310, reflecting concern...
Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...
Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...
